                         SEQUENCE LISTING

<110>  Cornell University
 
<120>  GENE THERAPY TO PREVENT REACTIONS TO ALLERGENS

<130>  723279

<150>  US 62/314,740
<151>  2016-03-29

<150>  US 62/145,035
<151>  2015-04-09

<160>  11    

<170>  PatentIn version 3.5

<210>  1
<211>  36
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Heavy Chain CDR-H3

<400>  1
cgccgtgagc ggctacagca tcaccagcgg ctacag                                 36


<210>  2
<211>  30
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Heavy Chain CDR-H2

<400>  2
cagcatcacc tacgacggca gcaccaacta                                        30


<210>  3
<211>  42
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Heavy Chain CDR-H3

<400>  3
cgctcggggc agccactact tcggccactg gcacttcgcc gt                          42


<210>  4
<211>  45
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Light Chain CDR-L1

<400>  4
ccgggctagc cagagcgtgg actacgacgg cgacagctac atgaa                       45


<210>  5
<211>  24
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Light Chain CDR-L2

<400>  5
ctacgctgcc agctacctgg agag                                              24


<210>  6
<211>  27
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Light Chain CDR-L3

<400>  6
ccagcagagc cacgaggacc cctacac                                           27


<210>  7
<211>  363
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Heavy Chain Variable Region

<400>  7
gaggtgcagc tggtggagag cggcggtggc ctggtgcagc ctggtggtag cctgcgcctg       60

agctgcgccg tgagcggcta cagcatcacc agcggctaca gctggaactg gatccggcag      120

gcccctggca agggcctgga gtgggtggcc agcatcacct acgacggcag caccaactac      180

gccgacagcg tgaagggccg gttcaccatc agccgggacg acagcaagaa caccttctac      240

ctgcagatga actccctgcg ggccgaggac accgccgtgt actactgcgc tcggggcagc      300

cactacttcg gccactggca cttcgccgtg tggggtcagg gcaccctggt gaccgtgagc      360

agc                                                                    363


<210>  8
<211>  330
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Light Chain Variable Region

<400>  8
gacatccagc tgacccagag ccctagcagc ctgagcgcca gcgtgggcga ccgggtgacc       60

atcacctgcc gggctagcca gagcgtggac tacgacggcg acagctacat gaattggtac      120

cagcagaagc ccggcaaggc tcccaagctg ctgatctacg ctgccagcta cctggagagc      180

ggcgtgccca gccggttcag cggcagcggc agcggcaccg acttcaccct gaccatcagc      240

agcctgcagc ccgaggactt cgccacctac tactgccagc agagccacga ggacccctac      300

accttcggcc agggcaccaa ggtggagatc                                       330


<210>  9
<211>  2214
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic Anti-IgE antibody

<400>  9
atggagttcg gcctgagctg gctgttcctg gtggccatcc tgaagggcgt gcagtgcgag       60

gtgcagctgg tggagagcgg cggtggcctg gtgcagcctg gtggtagcct gcgcctgagc      120

tgcgccgtga gcggctacag catcaccagc ggctacagct ggaactggat ccggcaggcc      180

cctggcaagg gcctggagtg ggtggccagc atcacctacg acggcagcac caactacgcc      240

gacagcgtga agggccggtt caccatcagc cgggacgaca gcaagaacac cttctacctg      300

cagatgaact ccctgcgggc cgaggacacc gccgtgtact actgcgctcg gggcagccac      360

tacttcggcc actggcactt cgccgtgtgg ggtcagggca ccctggtgac cgtgagcagc      420

gccagcacca agggccccag cgtgttccct ctggctccct cttccaaatc caccagcggc      480

ggcaccgctg ccctgggctg cctggtgaag gactacttcc ccgagcccgt gaccgtgagc      540

tggaacagcg gcgccctgac cagcggcgtg cacaccttcc ctgccgtgct gcaatccagc      600

ggcctgtaca gcctgagcag cgtcgtgacc gtgcccagca gcagcctggg cacccagacc      660

tacatctgca acgtgaacca caagcccagc aacaccaagg tggacaagaa ggccgagccc      720

aagagctgcg acaagaccca cacctgccct ccctgccccg cccctgagct gctcggcgga      780

cccagcgtgt tcctgttccc tcccaagccc aaggacaccc tgatgatcag ccggacccct      840

gaggtgacct gcgtggtcgt ggacgtgagc cacgaggacc ccgaggtgaa gttcaactgg      900

tatgtggacg gcgtggaggt gcacaacgcc aagaccaagc cccgggagga gcagtacaac      960

agcacctacc gggtggtgag cgtgctgacc gtgctgcacc aggactggct gaacggcaag     1020

gagtacaagt gcaaggtctc caacaaggcc ctgcctgccc ctatcgagaa gaccatcagc     1080

aaggccaagg gccagccccg ggagccccag gtgtacaccc tgcctcctag ccgggacgag     1140

ctgaccaaga accaggtctc cctgacctgc ctggtgaagg gcttctaccc cagcgacatc     1200

gccgtggagt gggagagcaa cggccagccc gagaacaact acaagaccac ccctcccgtg     1260

ctggacagcg acggcagctt cttcctgtac tccaagctga ccgtggacaa gagccggtgg     1320

cagcagggca acgtgttcag ctgcagcgtg atgcacgagg ccctgcacaa ccactacacc     1380

cagaagagcc tgagcctgag ccccggacgg aagcggagga gcggcgctcc tgtgaagcag     1440

accctgaact tcgacctgct gaagctggcc ggcgacgtgg agagcaaccc tgggcctatg     1500

aagtacctgc tgcccaccgc cgctgctggc ctgctcctgc tcgctgccca acccgctgct     1560

gacatccagc tgacccagag ccctagcagc ctgagcgcca gcgtgggcga ccgggtgacc     1620

atcacctgcc gggctagcca gagcgtggac tacgacggcg acagctacat gaattggtac     1680

cagcagaagc ccggcaaggc tcccaagctg ctgatctacg ctgccagcta cctggagagc     1740

ggcgtgccca gccggttcag cggcagcggc agcggcaccg acttcaccct gaccatcagc     1800

agcctgcagc ccgaggactt cgccacctac tactgccagc agagccacga ggacccctac     1860

accttcggcc agggcaccaa ggtggagatc aagcggaccg tggccgctcc tagcgtgttc     1920

atcttccctc cctccgacga gcagctgaag agcggcaccg ccagcgtggt gtgcctgctg     1980

aacaacttct accctcggga ggccaaggtg cagtggaagg tggacaacgc cctgcagagc     2040

ggcaacagcc aggagagcgt gaccgagcag gacagcaagg acagcaccta cagcctgagc     2100

agcaccctga ccctgagcaa ggccgactac gagaagcaca aggtgtacgc ctgcgaggtg     2160

acccaccagg gcctgagcag ccccgtgacc aagagcttca accggggcga gtgc           2214


<210>  10
<211>  1407
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic omalizumab heavy chain 

<400>  10
atggagttcg gcctgagctg gctgttcctg gtggccatcc tgaagggcgt gcagtgcgag       60

gtgcagctgg tggagagcgg cggtggcctg gtgcagcctg gtggtagcct gcgcctgagc      120

tgcgccgtga gcggctacag catcaccagc ggctacagct ggaactggat ccggcaggcc      180

cctggcaagg gcctggagtg ggtggccagc atcacctacg acggcagcac caactacgcc      240

gacagcgtga agggccggtt caccatcagc cgggacgaca gcaagaacac cttctacctg      300

cagatgaact ccctgcgggc cgaggacacc gccgtgtact actgcgctcg gggcagccac      360

tacttcggcc actggcactt cgccgtgtgg ggtcagggca ccctggtgac cgtgagcagc      420

gccagcacca agggccccag cgtgttccct ctggctccct cttccaaatc caccagcggc      480

ggcaccgctg ccctgggctg cctggtgaag gactacttcc ccgagcccgt gaccgtgagc      540

tggaacagcg gcgccctgac cagcggcgtg cacaccttcc ctgccgtgct gcaatccagc      600

ggcctgtaca gcctgagcag cgtcgtgacc gtgcccagca gcagcctggg cacccagacc      660

tacatctgca acgtgaacca caagcccagc aacaccaagg tggacaagaa ggccgagccc      720

aagagctgcg acaagaccca cacctgccct ccctgccccg cccctgagct gctcggcgga      780

cccagcgtgt tcctgttccc tcccaagccc aaggacaccc tgatgatcag ccggacccct      840

gaggtgacct gcgtggtcgt ggacgtgagc cacgaggacc ccgaggtgaa gttcaactgg      900

tatgtggacg gcgtggaggt gcacaacgcc aagaccaagc cccgggagga gcagtacaac      960

agcacctacc gggtggtgag cgtgctgacc gtgctgcacc aggactggct gaacggcaag     1020

gagtacaagt gcaaggtctc caacaaggcc ctgcctgccc ctatcgagaa gaccatcagc     1080

aaggccaagg gccagccccg ggagccccag gtgtacaccc tgcctcctag ccgggacgag     1140

ctgaccaaga accaggtctc cctgacctgc ctggtgaagg gcttctaccc cagcgacatc     1200

gccgtggagt gggagagcaa cggccagccc gagaacaact acaagaccac ccctcccgtg     1260

ctggacagcg acggcagctt cttcctgtac tccaagctga ccgtggacaa gagccggtgg     1320

cagcagggca acgtgttcag ctgcagcgtg atgcacgagg ccctgcacaa ccactacacc     1380

cagaagagcc tgagcctgag ccccgga                                         1407


<210>  11
<211>  645
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic omalizumab light chain

<400>  11
gacatccagc tgacccagag ccctagcagc ctgagcgcca gcgtgggcga ccgggtgacc       60

atcacctgcc gggctagcca gagcgtggac tacgacggcg acagctacat gaattggtac      120

cagcagaagc ccggcaaggc tcccaagctg ctgatctacg ctgccagcta cctggagagc      180

ggcgtgccca gccggttcag cggcagcggc agcggcaccg acttcaccct gaccatcagc      240

agcctgcagc ccgaggactt cgccacctac tactgccagc agagccacga ggacccctac      300

accttcggcc agggcaccaa ggtggagatc aagcggaccg tggccgctcc tagcgtgttc      360

atcttccctc cctccgacga gcagctgaag agcggcaccg ccagcgtggt gtgcctgctg      420

aacaacttct accctcggga ggccaaggtg cagtggaagg tggacaacgc cctgcagagc      480

ggcaacagcc aggagagcgt gaccgagcag gacagcaagg acagcaccta cagcctgagc      540

agcaccctga ccctgagcaa ggccgactac gagaagcaca aggtgtacgc ctgcgaggtg      600

acccaccagg gcctgagcag ccccgtgacc aagagcttca accgg                      645


